CORT CORCEPT THERAPEUTICS INC
Last updated: May 11, 2026
Execution Consistency
Did the company actually spend money buying back stock in 3+ of the last 4 quarters?
Bought back stock in 4/4 quarters. Q1 2026: $27M, Q3 2025: $12M, Q2 2025: $3M, Q1 2025: $0M
Execution Acceleration
Is the most recent quarter's buyback spend more than 15% above the trailing average?
Latest quarter $27M vs trailing avg $5M (+425%)
Buyback vs FCF
What percentage of free cash flow is going to buybacks? Bull: 30%+. Bear: negative FCF or no buybacks.
Negative FCF ($-38M), buybacks not supported by cash flow
Buyback Intensity
How fast are they shrinking the float? Bull: 2%+ annually. Bear: under 0.5%.
Repurchased 30,800,000 shares = 36.4% of 112,710,000 outstanding (annualized)
Insider Buying
Are officers and directors buying stock with their own money on the open market?
2 open-market purchases by 1 insiders
- BAKER G LEONARD JR () bought 75,782 shares at $33.00 on 2026-03-17
- BAKER G LEONARD JR () bought 24,218 shares at $33.56 on 2026-03-17
Insider-Buyback Convergence
Are both company buybacks and insider buying independently active? Bull when the company is buying back stock in 2+ quarters and insiders have made 2+ open-market purchases.
Company buybacks in 4 quarters and 2 insider purchases by 1 insiders (no calendar overlap, but both independently active)
Insider Net Direction
Over the last 90 days, are insiders net buyers or net sellers on the open market?
Insiders bought $3M, sold $6M in the last 90 days (net selling)
Red Flag
Active buyback + insiders net selling 3x+ more than buying. Company cash may be supporting price while insiders exit.
Company buying back stock while insiders sold 16.9x more than bought. 3 C-suite officers among sellers
- Guyer William (Chief Development Officer) sold 20,000 shares on 2026-05-05
- BELANOFF JOSEPH K (Chief Executive Officer) sold 40,000 shares on 2026-05-01
- Guyer William (Chief Development Officer) sold 20,000 shares on 2026-04-07
- BELANOFF JOSEPH K (Chief Executive Officer) sold 26,198 shares on 2026-03-25
- Guyer William (Chief Development Officer) sold 11,767 shares on 2026-03-20
- Guyer William (Chief Development Officer) sold 8,233 shares on 2026-03-04
- Guyer William (Chief Development Officer) sold 20,000 shares on 2026-02-03
- Guyer William (Chief Development Officer) sold 20,000 shares on 2026-01-06
- Guyer William (Chief Development Officer) sold 19,360 shares on 2025-12-02
- Guyer William (Chief Development Officer) sold 640 shares on 2025-12-02